In pediatric patients with smoke inhalation, hydroxocobalamin should be given under which condition?

In pediatric patients with smoke inhalation, hydroxocobalamin should be given under which condition?

• A. Cardiac arrest only
• B. Hypotension only
• C. Profound altered mental status only
• D. Cardiac arrest, hypotension, or profound altered mental status

Answer: (D)

Cyanide poisoning from smoke inhalation is a real concern in children because cyanide disrupts cellular oxygen utilization, leading to rapid deterioration of brain and heart function. When cyanide is present, signs can include sudden mental status changes, profound hypotension, and cardiac arrest as tissues become unable to use oxygen despite adequate blood oxygenation. Hydroxocobalamin works by binding cyanide to form cyanocobalamin, which is safely excreted, effectively reversing the toxic effects at the cellular level. Because a child with smoke inhalation can deteriorate quickly, the antidote is indicated whenever there are strong signs of cyanide toxicity—specifically cardiac arrest, low blood pressure, or pronounced alteration in mental status. Treating promptly in these scenarios helps restore cellular respiration and improves outcomes. Choosing to administer hydroxocobalamin only for one isolated sign would miss other high-risk presentations, whereas these severe indicators capture the range of cyanide toxicity that demands antidotal therapy in pediatric patients.

Cyanide poisoning from smoke inhalation is a real concern in children because cyanide disrupts cellular oxygen utilization, leading to rapid deterioration of brain and heart function. When cyanide is present, signs can include sudden mental status changes, profound hypotension, and cardiac arrest as tissues become unable to use oxygen despite adequate blood oxygenation.

Hydroxocobalamin works by binding cyanide to form cyanocobalamin, which is safely excreted, effectively reversing the toxic effects at the cellular level. Because a child with smoke inhalation can deteriorate quickly, the antidote is indicated whenever there are strong signs of cyanide toxicity—specifically cardiac arrest, low blood pressure, or pronounced alteration in mental status. Treating promptly in these scenarios helps restore cellular respiration and improves outcomes.

Choosing to administer hydroxocobalamin only for one isolated sign would miss other high-risk presentations, whereas these severe indicators capture the range of cyanide toxicity that demands antidotal therapy in pediatric patients.